9 March, 2026 | 1:55 PM
Will red merge with Saffron?
09-03-2026
TG considering providing e-scooters to female students: CM
09-03-2026
‘Women entrepreneurs to drive economic empowerment in AP’
09-03-2026
BJP slams CM’s Kerala poll campaign
09-03-2026
COUNCIL hall restored to its past glory
09-03-2026
Collector helps woman reclaim her home
09-03-2026
Latest News
Market/Money
India shifts oil imports amid Middle East tensions
09-03-2026
Indian refiners are actively seeking crude oil supplies from the United States, Russia, West Africa, and Latin America as escalating tensions in the Middle East raise concerns over energy security.
Punjab FY27 budget prioritizes women and welfare
09-03-2026
Punjab Finance Minister Harpal Singh Cheema presented the state’s budget for 2026-27, allocating Rs 2,60,437 crore. Speaking in the assembly, Cheema said this is the last budget of the Aam Aadmi Party government before the 2027 polls and highlighted that every promise made to the people has been fulfilled.
AC prices set to rise ahead of summer
09-03-2026
Leading room airconditioner makers are increasing prices by 5-15% between February and April as raw material costs, a weak rupee, and new energy-efficiency norms push up expenses. The hikes come just before the peak summer season, when demand typically surges.
FPIs pull out Rs 21,000 crore amid West Asia crisis
09-03-2026
Foreign portfolio investors (FPIs) withdrew about Rs 21,000 crore from Indian equities in the last four trading sessions, spooked by escalating tensions in West Asia.
WTO Ministers to discuss trade, agriculture
09-03-2026
Trade ministers from 166 countries are set to meet at the 14th World Trade Organisation (WTO) Ministerial Conference (MC14) in Yaounde, Cameroon, from March 26 to 29, 2026, to discuss reforms, agriculture, dispute settlement, and the e-commerce moratorium. The Indian delegation will be led by Commerce and Industry Minister Piyush Goyal.
Cipla recalls over 400 cartons of cancer drug in US
09-03-2026
Cipla’s US subsidiary is recalling more than 400 cartons of its generic anti-cancer drug Nilotinib in the United States due to a manufacturing issue, the US Food and Drug Administration (USFDA) has reported.
6
